This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Kuban, K. C.K. Articles by Wolff, M. Search for Related Content PubMed PubMed Citation Articles by Kuban, K. C.K. Articles by Wolff, M. Social Bookmarking                   What's this?

Maternal Toxemia Is Associated With Reduced Incidence of Germinal Matrix Hemorrhage in Premature Babies

Department of Neurology, Children's Hospital and Harvard Medical School

Alan Leviton, MD

Department of Neurology, Children's Hospital and Harvard Medical School

Marcello Pagano, PhD

Department of Neurology, Children's Hospital and Harvard Medical School

Terence Fenton, EdD

Department of Neurology, Children's Hospital and Harvard Medical School

Ruth Strassfeld

Department of Neurology, Children's Hospital and Harvard Medical School

Mildred Wolff, MA

Department of Neurology, Children's Hospital and Harvard Medical School

To evaluate prenatal and perinatal risk factors for development of germinal matrix hemorrhage-intraventricular hemorrhage (GMH-IVH), we conducted a prospective epidemiologic study of 449 babies whose birth weight was less than 1501 grams. This study permitted us to test our previously generated hypothesis that babies born to mothers with preeclampsia were at substantially reduced risk of developing GMH-IVH. Seventy-two (16%) of the babies in this population developed GMH-IVH. One (2.5%) of the 40 mothers with a diagnosis of preeclampsia and 71 (17.4%) of 409 mothers without preeclampsia gave birth to babies who developed GMH-IVH. GMH-IVH was seen in 6/107 (5.6%) of babies born to women with hypertension including 4/69 (5.8%) of babies born to women with pregnancy-induced hypertension, compared to 66/352 (18.8%) of babies born to mothers who did not have hypertension. Only 7.3% (8/108) of babies born to women who had proteinuria had GMH-IVH, compared to 18.3% (64/350) of babies whose mothers did not have proteinuria. GMH-IVH was seen in 5/89 (5.6%) of babies whose mothers had both hypertension and proteinuria, whereas 63/332 (19%) of babies born to mothers who lacked both factors, developed GMH-IVH. In stepwise logistic regression analysis, these significant findings were not explained by the presence of labor, postnatal acidemia, need for intubation, antenatal administration of steroids, birth weight, or gestational age. In addition, we found that maternal receipt of magnesium sulfate was associated with diminished risk of GMH-IVH even in those babies born to mothers who apparently did not have preeclampsia. We postulate that the association of preeclampsia and GVH-IVH may be related to prostaglandin effects. Reduced maternal, placental, and umbilical prostaglandin I₂ (PGI₂) values are characteristic of women with preeclampsia. Thus, babies born to mothers with preeclampsia may have a physiologic state similar to those having received indomethacin, a cyclooxygenase blocker that causes diminished PGI₂ levels and an effective GMH-IVH prophylactic agent. We conclude that early third-trimester maternal preeclampsia/toxemia is associated with reduced risk of GMH-IVH in the preterm newborn. (J Child Neurol 1992;7:70-76).

Journal of Child Neurology, Vol. 7, No. 1, 70-76 (1992)
DOI: 10.1177/088307389200700113


CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				C. A. Crowther, J. E. Hiller, L. W. Doyle, and R. R. Haslam Effect of Magnesium Sulfate Given for Neuroprotection Before Preterm Birth: A Randomized Controlled Trial JAMA, November 26, 2003; 290(20): 2669 - 2676. [Abstract] [Full Text] [PDF]

				Z Weintraub, M Solovechick, B Reichman, A Rotschild, D Waisman, O Davkin, A Lusky, and Y Bental Effect of maternal tocolysis on the incidence of severe periventricular/intraventricular haemorrhage in very low birthweight infants Arch. Dis. Child. Fetal Neonatal Ed., July 1, 2001; 85(1): F13 - 17. [Abstract] [Full Text] [PDF]

				P. H Gray, M. J O'Callaghan, H. A Mohay, Y. R Burns, and J. F King Maternal hypertension and neurodevelopmental outcome in very preterm infants Arch. Dis. Child. Fetal Neonatal Ed., September 1, 1998; 79(2): 88F - 93. [Abstract] [Full Text]

				D. Wilson-Costello, E. Borawski, H. Friedman, R. Redline, A. A. Fanaroff, and M. Hack Perinatal Correlates of Cerebral Palsy and Other Neurologic Impairment Among Very Low Birth Weight Children Pediatrics, August 1, 1998; 102(2): 315 - 322. [Abstract] [Full Text] [PDF]

				A. R. Hansen, E. N. Allred, and A. Leviton Predictors of Ventriculoperitoneal Shunt Among Babies With Intraventricular Hemorrhage J Child Neurol, September 1, 1997; 12(6): 381 - 386. [Abstract] [PDF]

				N. Paneth, J. Jetton, J. Pinto-Martin, M. Susser, and the Neonatal Brain Hemorrhage Study Analysis Group Magnesium Sulfate in Labor and Risk of Neonatal Brain Lesions and Cerebral Palsy in Low Birth Weight Infants Pediatrics, May 1, 1997; 99(5): e1 - e1. [Abstract] [Full Text] [PDF]

				E. N. Allred, O. Dammann, K. K. C. Kuban, A. Leviton, M. Pagano, J. E. Stewart, and L. J. VanMarter Prenatal Magnesium Sulfate Exposure and Risk of Cerebral Palsy JAMA, April 2, 1997; 277(13): 1033 - 1033. [Abstract] [PDF]

				A. Leviton, N. Paneth, M. Susser, M. L. Reuss, E. N. Allred, K. Kuban, U. Sanocka, T. Hegyi, M. Hiatt, F. Shahrivar, et al. Maternal Receipt of Magnesium Sulfate Does Not Seem to Reduce the Risk of Neonatal White Matter Damage Pediatrics, April 1, 1997; 99(4): e2 - e2. [Abstract] [Full Text] [PDF]

				D. E. Schendel, C. J. Berg, M. Yeargin-Allsopp, C. A. Boyle, and P. Decoufle Prenatal Magnesium Sulfate Exposure and the Risk for Cerebral Palsy or Mental Retardation Among Very Low-Birth-Weight Children Aged 3 to 5 Years JAMA, December 11, 1996; 276(22): 1805 - 1810. [Abstract] [PDF]

				C.-R. Kim, B. R. Vohr, and W. Oh Effects of Maternal Hypertension in Very-Low-Birth-Weight Infants Arch Pediatr Adolesc Med, July 1, 1996; 150(7): 686 - 691. [Abstract] [PDF]

				S. Shankaran, C. R. Bauer, R. Bain, L. L. Wright, and J. Zachary Prenatal and Perinatal Risk and Protective Factors for Neonatal Intracranial Hemorrhage Arch Pediatr Adolesc Med, May 1, 1996; 150(5): 491 - 497. [Abstract] [PDF]